Nuvation Bio Q4 EPS $(0.11) Misses $(0.09) Estimate, Sales $41.865M Beat $37.326M Estimate
Nuvation Bio (NYSE:NUVB) reported quarterly losses of $(0.11) per share which missed the analyst consensus estimate of $(0.09) by 22.22 percent. This is a 26.67 percent increase over losses of $(0.15) per share from the
